Home › Funds › Ninety One UK Ltd › EW

Ninety One UK Ltd position in EW

EDWARDS LIFESCIENCES CORP · Health Care

Ninety One UK Ltd reported holding 11,943,675 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q3 2026 13F filing — a position valued at US$1.03B, representing 2.27% of its reported portfolio and ranking #10 among its reported holdings. Ninety One UK Ltd has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)11.94M sh
Reported value held$1.03B
Portfolio Weight2.27%
First reportedQ3 2023
Last changeReduce
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How Ninety One UK Ltd's EW position evolved

Ninety One UK Ltd first disclosed a stake in EW in Q3 2023 at 17,533 shares (US$1.2M). The position peaked in Q2 2026 at 12,337,502 shares, worth US$1.12B. Across 13 filings, Ninety One UK Ltd increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 11,943,675 shares valued at US$1.03B — a reduction of -393,827 shares quarter over quarter.. Notable position changes include a 2741% increase in Q4 2023 (shares rose 25% over the following quarter), a 1659% increase in Q3 2024 (shares rose 12% over the following quarter), a 60% increase in Q1 2026 (shares rose 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 17.53K $1.21M New
Q4 2023 498.03K $37.97M Add
Q1 2024 599.32K $57.27M Add
Q2 2024 415.76K $38.40M Reduce
Q3 2024 7.31M $482.50M Add
Q4 2024 7.18M $531.88M Reduce
Q1 2025 7.00M $507.68M Reduce
Q2 2025 6.94M $542.74M Reduce
Q3 2025 7.91M $615.05M Add
Q4 2025 7.73M $659.40M Reduce
Q1 2026 12.40M $992.68M Add
Q2 2026 12.34M $1.12B Hold
Q3 2026 11.94M $1.03B Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EW and 13F data

EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 33 other funds we track also report a position in EW — the largest reported positions include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Aristotle Capital Management, LLC (US$783.9M), BROWN ADVISORY INC (US$666.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EW

All EW fund holders →

FAQ

How long has Ninety One UK Ltd held EW?

Ninety One UK Ltd has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Ninety One UK Ltd's current position in EW?

As of Q3 2026, Ninety One UK Ltd holds 11.94M shares of EW (EDWARDS LIFESCIENCES CORP), valued at $1.03B, representing 2.27% of its reported portfolio and ranking #10.

Has Ninety One UK Ltd been buying or selling EW?

In the latest 13F filing (Q3 2026), Ninety One UK Ltd reduced its position in EW. The position peaked in Q2 2026 at 12.34M shares.

Which other funds hold EW?

Other major institutional holders of EW include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Aristotle Capital Management, LLC, BROWN ADVISORY INC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.